Mirum Pharmaceuticals, Inc. (MIRM) Operating income 2019–2025
Mirum Pharmaceuticals, Inc. (MIRM) annual operating income history from SEC filings — each fiscal year as reported.
-$22.1MFY2025 · since FY2019: -$54.7M → -$22.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$22.1M | +74.7% |
| FY2024 | -$87.6M | +19.7% |
| FY2023 | -$109.2M | +16.8% |
| FY2022 | -$131.2M | +24.3% |
| FY2021 | -$173.4M | -66.3% |
| FY2020 | -$104.3M | -90.5% |
| FY2019 | -$54.7M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More MIRM financial trends
MIRM RevenueMIRM Net incomeMIRM Net marginMIRM Gross profitMIRM Gross marginMIRM Operating marginMIRM Operating cash flowMIRM Free cash flowMIRM Capital expendituresMIRM Return on equityMIRM Stock buybacksMIRM Dividends paidMIRM Total assetsMIRM Total liabilitiesMIRM Shareholders’ equityMIRM overview →